Cytokeratin 19 fragment in serum and tissues of patients with pancreatic diseases
- 1 June 1997
- journal article
- clinical trial
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 21 (3), 235-241
- https://doi.org/10.1007/bf02821609
Abstract
The present study has shown that increased serum levels of cytokeratin 19 fragment reflect increases in the size of the pancreatic carcinomas, although the sensitivity for detecting small pancreatic carcinomas was low.Keywords
This publication has 18 references indexed in Scilit:
- SERUM CYTOKERATIN-19 MEASURED BY CYFRA21-1 ASSAY IN PATIENTS WITH GASTROINTESTINAL AND GYNECOLOGIC MALIGNANCYInternational Journal of Oncology, 1994
- Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tractZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- CYFRA 21-1: A new marker in lung cancerCancer, 1993
- Characterization of the Cytokeratins of Human Colonic, Pancreatic, and Gastric Adenocarcinoma Cell LinesPancreas, 1992
- Changes in the distribution of intermediate filament proteins and collagen IV in fetal and adult human pancreasHistochemistry and Cell Biology, 1991
- MOLECULAR AND CELLULAR BIOLOGY OF INTERMEDIATE FILAMENTSAnnual Review of Biochemistry, 1988
- Looking for a functionNature, 1987
- Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico‐histopathological correlation in a series of 75 casesHistopathology, 1985
- Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells.Proceedings of the National Academy of Sciences, 1983
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsCell, 1982